Exchange Traded Concepts, LLC Enanta Pharmaceuticals Inc Transaction History

Exchange Traded Concepts, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$41.02 - $58.65 $827,332 - $1.18 Million	-20,169 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$43.76 - $53.11 $83,844 - $101,758	1,916 Added 10.5%	20,169 $888,000
Q1 2021 Apr 20, 2021	BUY	$41.69 - $54.95 $465,844 - $614,011	11,174 Added 157.85%	18,253 $900,000
Q4 2020 Jan 19, 2021	BUY	$41.16 - $47.47 $13,335 - $15,380	324 Added 4.8%	7,079 $298,000
Q3 2020 Oct 30, 2020	BUY	$43.36 - $53.53 $292,896 - $361,595	6,755 New	6,755 $309,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.